SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-168396
Filing Date
2022-06-06
Accepted
2022-06-06 16:36:06
Documents
15
Period of Report
2022-06-01
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100724d8k.htm   iXBRL 8-K 40240
2 EX-99.1 d100724dex991.htm EX-99.1 25724
3 EX-99.2 d100724dex992.htm EX-99.2 9775
7 GRAPHIC g100724g0606171951610.jpg GRAPHIC 11129
  Complete submission text file 0001193125-22-168396.txt   234674

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrn-20220601.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20220601_lab.xml EX-101.LAB 18690
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20220601_pre.xml EX-101.PRE 11693
9 EXTRACTED XBRL INSTANCE DOCUMENT d100724d8k_htm.xml XML 3878
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 22998522
SIC: 2834 Pharmaceutical Preparations